Ivermectin is a Nobel Prize-winning wonder drug – but not for COVID-19

Ivermectin has been a lifesaving drug for people with parasitic infections like river blindness and strongyloidiasis. But taking it for COVID-19 may result in the opposite effect.

Related Keywords

Australia ,China ,Japan ,United States ,Kitasato ,Japan General ,Japanese ,America ,American ,Satoshi Omura ,William Campbell ,Centers For Disease ,Mectizan Donation Program ,National Institutes Of Health ,World Health Organization ,Drug Administration ,Kitasato Institute ,Infectious Diseases Society Of America ,Merck Pharmaceuticals ,Nobel Prize ,Disease Control ,National Institutes ,Infectious Diseases Society ,Antimicrobial ,Covid 19 ,Chloroquine ,Drug Development ,Hydroxychloroquine ,Infections ,Infectious Diseases ,Ivermectin ,Leishmaniasis ,Merck ,Obel Prize 2015 ,Parasitic Infections ,River Blindness ,